Multiple sclerosis treatment blunts SARS-CoV-2 antibody response. Lempriere S. Nat Rev Neurol 2021 Aug 9. pii: 10.1038/s41582-021-00551.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lempriere S. Multiple sclerosis treatment blunts SARS-CoV-2 antibody response. Nat Rev Neurol 2021 Aug 9. pii: 10.1038/s41582-021-00551.
PMID: 34373633